PBM vs. NIVF, CERO, BCDA, GHSI, GRTX, ONVO, ERNA, CHRO, NVOS, and TBIO
Should you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include NewGenIvf Group (NIVF), CERo Therapeutics (CERO), BioCardia (BCDA), Guardion Health Sciences (GHSI), Galera Therapeutics (GRTX), Organovo (ONVO), Eterna Therapeutics (ERNA), Chromocell Therapeutics (CHRO), Novo Integrated Sciences (NVOS), and Telesis Bio (TBIO). These companies are all part of the "medical" sector.
Psyence Biomedical (NASDAQ:PBM) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings, community ranking and profitability.
Psyence Biomedical has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500.
Psyence Biomedical and NewGenIvf Group both received 0 outperform votes by MarketBeat users.
77.4% of Psyence Biomedical shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 3.6% of Psyence Biomedical shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, Psyence Biomedical had 1 more articles in the media than NewGenIvf Group. MarketBeat recorded 2 mentions for Psyence Biomedical and 1 mentions for NewGenIvf Group. NewGenIvf Group's average media sentiment score of 1.89 beat Psyence Biomedical's score of 0.93 indicating that NewGenIvf Group is being referred to more favorably in the news media.
Summary
NewGenIvf Group beats Psyence Biomedical on 3 of the 5 factors compared between the two stocks.
Get Psyence Biomedical News Delivered to You Automatically
Sign up to receive the latest news and ratings for PBM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PBM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Psyence Biomedical Competitors List
Related Companies and Tools
